Arrowhead Pharmaceuticals, Inc. revenue for the last year amounted to 240.74 M USD, the most of which — 240.74 M USD — came from its highest performing source at the moment, Innovative Drugs, the year earlier bringing 243.23 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Arrowhead Pharmaceuticals, Inc. 240.74 M USD, and the year before that — 243.23 M USD.